A randomized trial of low-dose Aspirin in the prevention of clinical type 2 Diabetes in women

Diabetes Care

Volumn 32, Issue 1, 2009, Pages 3-8

  Pradhan, Aruna D ^a,b   Cook, Nancy R ^a   Manson, Joann E ^a   Ridker, Paul M ^a   Buring, Julie E ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; C REACTIVE PROTEIN; PLACEBO;

ADULT; AGED; ARTICLE; BLEEDING; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EPISTAXIS; FEMALE; FOLLOW UP; HEMATURIA; HUMAN; LONG TERM CARE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PEPTIC ULCER; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TREATMENT DURATION;

AGED; ASPIRIN; CARDIOTONIC AGENTS; CARDIOVASCULAR DISEASES; CONTINENTAL POPULATION GROUPS; DIABETES MELLITUS, TYPE 2; ETHNIC GROUPS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INCIDENCE; MIDDLE AGED; PATIENT COMPLIANCE; PLACEBOS; PRIMARY PREVENTION; RISK ASSESSMENT; VITAMIN E;

EID: 63049115671     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-1206     Document Type: Article

References (25)

1. Ebstein W: Zur therapie des diabetes mellitus, insbesondere uber die anwendeng der salicylauren natron bei demselben. Berlin Klin Wochenschr 13:337-340, 1876
2. Shoelson SE, Lee J, Goldfine AB: Inflammation and insulin resistance. J Clin Invest 116:1793-1801, 2006
3. Thorand B, Baumert J, Kolb H, Meisinger C, Chambless L, KoenigW,Herder C: Sex differences in the prediction of type 2 diabetes by inflammatory markers: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Diabetes Care 30:854-860, 2007
4. Fleischman A, Shoelson SE, Bernier R, Goldfine AB: Salsalate improves glycemia and inflammatory parameters in obese young adults. Diabetes Care 31:289-294, 2008
5. β. Science 293:1673-1677, 2001
6. Gao Z, Zuberi A, Quon MJ, Dong Z, Ye J: Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in tumor necrosis factor-treated cells through targeting multiple serine kinases. J Biol Chem 278:24944-24950, 2003
7. Reid J, Lightbody TD: The insulin equivalence of salicylate. Br Med J 1:897-900, 1959
8. Micossi P, Pontiroli AE, Baron SH, Tamayo RC, Lengel F, Bevilacqua M, Raggi U, Nor-biato G, Foa PP: Aspirin stimulates insulin and glucagon secretion and increases glucose tolerance in normal and diabetic subjects. Diabetes 27:1196-1204, 1978
9. Prince RL, Larkins RG, Alford FP: The effect of acetylsalicylic acid on plasma glucose and the response of glucose regulatory hormones to intravenous glucose and arginine in insulin treated diabetics and normal subjects. Metabolism 30:293-298, 1981
10. Hundal RS, Petersen KF, Mayerson AB, Randhawa PS, Inzucchi S, Shoelson SE, Shulman GI: Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J Clin Invest 109: 1321-1326, 2002
11. Chiang N, Bermudez EA, Ridker PM, Hurwitz S, Serhan CN: Aspirin triggers antiinflammatory 15-epi-lipoxin A4 and inhibits thromboxane in a randomized human trial. Proc Natl Acad Sci USA 101: 15178-15183, 2004
12. Santilli F, Davi G, Consoli A, Cipollone F, Mezzetti A, Falco A, Taraborelli T, Devan-gelio E, Ciabattoni G, Basili S, Patrono C: Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus. J Am Coll Cardiol 47:391-397, 2006
13. Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, Hennekens CH, Buring JE: A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 352:1293-1304, 2005
14. Cook NR, Lee IM, Gaziano JM, Gordon D, Ridker PM, Manson JE, Hennekens CH, Buring JE: Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA 294:47-55, 2005
15. Lee IM, Cook NR, Gaziano JM, Gordon D, Ridker PM, Manson JE, Hennekens CH, Buring JE: Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA 294: 56-65, 2005
16. Rexrode KM, Lee IM, Cook NR, Hennekens CH, Buring JE: Baseline characteristics of participants in the Women's Health Study. J Womens Health Gend Based Med 9:19-27, 2000
17. Liu S, Lee IM, Song Y, Van Denburgh M, Cook NR, Manson JE, Buring JE: Vitamin E and risk of type 2 diabetes in the Women's Health Study randomized controlled trial. Diabetes 55:2856-2862, 2006
18. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
19. Ding EL, Song Y, Manson JE, Pradhan AD, Buring JE, Liu S: Accuracy of administrative coding for type 2 diabetes in children, adolescents, and young adults. Diabetes Care 30:e98, 2007; author reply e99
20. Ealovega MW, Tabaei BP, Brandle M, Burke R, Herman WH: Opportunistic screening for diabetes in routine clinical practice. Diabetes Care 27:9-12, 2004
21. Lee IM, Cook NR, Manson JE, Buring JE, Hennekens CH: β-Carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study. J Natl Cancer Inst 91:2102-2106, 1999
22. Giugliano D, Torella R, Siniscalchi N, Im-prota L, D'Onofrio F: The effect of acetylsalicylic acid on insulin response to glucose and arginine in normal man. Diabetologia 14:359-362, 1978
23. Newman WP, Brodows RG: Aspirin causes tissue insensitivity to insulin in normal man. J Clin Endocrinol Metab 57: 1102-1106, 1983
24. Bratusch-Marrain PR, Vierhapper H, Komjati M, Waldhausl WK: Acetyl-sali-cylic acid impairs insulin-mediated glucose utilization and reduces insulin clearance in healthy and non-insulin-dependent diabetic man. Diabetologia 28: 671-676, 1985
25. Centers for Disease Control and Prevention: National Diabetes Surveillance System: incidence of diabetes [article online], 2007. Available from http://www.cdc.gov/diabetes/statistics/incidence/table5.htm. Accessed 21 May 2008